AI-ECG Tracker vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Shenzhen Carewell Electronics Co.
VS
by Cardiomo, Inc.

AI Verdict

Tool A, AI-ECG Tracker, focuses on professional ECG auto-diagnosis within clinical settings, offering high-accuracy analysis of 12-lead ECG data. Tool B, Cardiomo, provides continuous, remote heart health monitoring through a wearable device and AI platform, emphasizing real-time alerts and patient-centric data for early detection. While both address cardiology with AI, Tool A is geared towards diagnostic workflows in healthcare facilities, whereas Tool B is designed for ongoing, at-home patient monitoring.

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your clinical setting requires rapid, highly accurate, and comprehensive 12-lead ECG auto-analysis for a wide range of cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. This tool is ideal for hospitals and emergency departments needing on-premise solutions with powerful computing for quick diagnoses and detailed report generation by medical professionals. It excels in scenarios where a definitive, in-depth ECG interpretation is paramount for immediate clinical decision-making.

View AI-ECG Tracker →

Choose Cardiomo if…

Choose Cardiomo if you need a continuous, remote heart health monitoring solution for patients, particularly for long-term management of cardiovascular diseases and timely alerts to users and caregivers. This medical-grade wearable is best suited for geriatrics, internal medicine, and cardiology practices focused on proactive patient monitoring outside of a clinical setting, offering features like fall detection and extended battery life for consistent oversight. It's designed to provide real-time insights and notifications for potential cardiac events, enabling early intervention and improved patient outcomes through continuous data collection and AI-powered analysis.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Tracker Cardiomo
Pricing Not publicly available Contact for pricing
Deployment On-premise (AI-ECG Workstation, Diagnostic Client) with optional cloud service (Lepu Nebula Cloud) for remote diagnostic services. Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiomo

Cardiomo offers a wearable patch and mobile app, suggesting a more user-friendly experience for continuous, remote monitoring by patients and caregivers. AI-ECG Tracker, while powerful, appears to be a more complex system designed for healthcare professionals within a clinical setting, involving workstations and diagnostic clients. Cardiomo's focus on ease of use for patients and relatives, with features like instant notifications and a simple app interface, makes it more accessible for a broader user base.

Clinical Value

AI-ECG Tracker

AI-ECG Tracker boasts high accuracy (over 95%) for a comprehensive range of cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, and is FDA-cleared. Cardiomo also offers AI-powered disease detection and real-time alerts, with claims of 99.63% accuracy for detecting cardiac events, but its FDA approval status is still in progress. AI-ECG Tracker's established FDA clearance and broad diagnostic capabilities for complex conditions give it a stronger clinical value for professional diagnosis.

Pricing & Value

Tie

Neither tool provides publicly available pricing, making a direct comparison of value difficult. Both require contacting the company for details. While Cardiomo previously offered a consumer-oriented price, its current pricing is not transparent, and AI-ECG Tracker is clearly an enterprise solution.

Enterprise Readiness

AI-ECG Tracker

AI-ECG Tracker is explicitly designed for enterprise use with an on-premise AI-ECG Workstation, a web-based Management Portal for organization settings, and a professional diagnostic client. It also has FDA clearance, which is crucial for enterprise adoption in the US healthcare market. Cardiomo, while HIPAA compliant and offering a BAA, appears more geared towards individual patient monitoring, though it does have aspirations for broader healthcare integration.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. AI-ECG Tracker applies AI to traditional 12-lead ECG auto-diagnosis with high accuracy and rapid results. Cardiomo innovates with a medical-grade wearable patch for continuous, remote monitoring and AI-powered disease detection with real-time alerts. Both are pushing the boundaries of AI in cardiology, albeit with different approaches and target users.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details about the level of customer support or documentation available for either product. Therefore, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Tracker Cardiomo
Company Shenzhen Carewell Electronics Co. (a subsidiary of Lepu Medical) Cardiomo, Inc.
Description Pioneer in applying artificial intelligence technology to ECG auto-diagnosis, distributing innovative AI medical devices to over 100 countries. Offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Key Features AI-powered ECG auto-analysis and diagnosis; High accuracy (over 95%) for common cardiac abnormalities; Supports 12-lead ECG data collection; AI-ECG Workstation with powerful GPU for fast computing; Web-based Management Portal; Window-based professional ECG diagnostic client; Rapid diagnosis in approximately 3 seconds; Comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications. Medical-grade wearable patch; Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature); AI-powered disease detection (arrhythmias, cardiovascular events); Real-time alerts and notifications; Mobile application (Android and iOS); HIPAA-compliant cloud analytics; Fall detection; Long battery life (up to 7-10 days).
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Emergency Medicine Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Tracker and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-ECG Tracker offers an on-premise workstation with an optional cloud service, suggesting integration would likely involve data exchange with the EHR for ECG data and diagnostic reports. Cardiomo, being cloud-based with a wearable and mobile app, would likely integrate by pushing continuous monitoring data and alerts into the EHR, potentially streamlining remote patient monitoring workflows. Both aim to augment, not replace, existing systems, with successful AI integration requiring deep understanding of clinical workflows.
AI-ECG Tracker boasts high accuracy (over 95%) for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, and supports 104 ECG diagnostic classifications. Cardiomo's AI-powered platform is designed to detect cardiovascular diseases and provide timely alerts, with proprietary algorithms trained to detect arrhythmias and other cardiac events.
AI-ECG Tracker is primarily focused on cardiology and emergency medicine, offering rapid, comprehensive ECG auto-analysis for a wide range of cardiac classifications. Cardiomo is suited for cardiology, geriatrics, and internal medicine, emphasizing continuous, remote monitoring for early detection of cardiovascular diseases and providing life-saving alerts, which is particularly beneficial for managing chronic conditions and at-risk populations.
While specific learning curve details aren't provided, AI tools should ideally be embedded within existing EHR workflows to minimize disruption and reduce the learning curve. AI-ECG Tracker's professional ECG diagnostic client suggests a tool for specialists, while Cardiomo's mobile application and real-time alerts imply a user-friendly interface for both patients and caregivers, potentially simplifying staff training for remote monitoring.
Both companies operate in the healthcare sector, implying adherence to security best practices. Cardiomo explicitly states HIPAA compliance and a BAA. For AI-ECG Tracker, a BAA is likely given its US operations. General AI-EHR integration security requirements include end-to-end encryption, strict access controls, data anonymization for model training, and comprehensive audit trails for every AI interaction with patient data.
AI-ECG Tracker's on-premise workstation with an optional cloud service could allow for centralized management via its Web-based Management Portal, facilitating consistent settings and task management across multiple sites. Cardiomo's cloud-based deployment inherently supports multi-site rollouts by providing a centralized platform for data aggregation and access from various locations, which is crucial for managing patient data across broad geographies.

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.